North America Toxicology Laboratories Market Will Reach US$ 198.2 Mn by 2022: PMR
Summary
New York, NY, March 18, 2016 --( The North America Toxicology Laboratories market is expected to reach US$ 198.2 Mn by the end of 2022 at a CAGR of 11.1% during the forecast period.On the basis of drug class, the North America toxicology laboratories market is segmented into alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs.On the basis of drug class, the North America toxicology laboratories market is segmented into alcohol, amphetamines, barbiturates, benzodiazepines, opiates/opioids, tricyclic antidepressants, and Z-Drugs.This is attributed to substantially high levels of drug abuse and unregulated prescribing patterns for hallucination drugs such as amphetamines, barbiturates, benzodiazepines, tricyclic antidepressants, and Z Drugs.The report begins with an overview of the North America toxicology laboratories market in terms of value, and a detailed analysis of key trends, drivers, and restraints, and opportunities, which are the main factors impelling growth of the toxicology laboratories market are covered in this section.The report provides in-depth information on the potential scope of high-end confirmatory testing instruments to provide clients with crystal clear decision-making insights.View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/north-america-toxicology-laboratories-market.aspKey players operating in the North America toxicology laboratories market include Thermo Fisher Scientific, Agilent Technologies, Bio Rad Laboratories Inc., Alere Inc., Eurofins Scientific, Neogen Corporation, Enzo Life Sciences, Inc., and Vala Sciences Inc.